Rivastigmine Patch (TAHO Pharmaceuticals)

N/A

Report date: 2026/01/04 17:56:03

Base Information

Drug NameRivastigmine Patch (TAHO Pharmaceuticals)
Drug Alias NameTAH8803TAH-8803
ClassificationSmall molecules
Mechanisms of ActionAcetylcholinesterase inhibitorsButyrylcholinesterase inhibitors
TargetsAcetylcholinesteraseButyrylcholinesterase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTAHO Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTAHO Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A